Biotech company Moderna, headquartered in Cambridge, Massachusetts, announced today that it is beginning Phase 3 trials of its COVID-19 vaccine. It will enroll up to 30,000 volunteers.
Maddie Meyer/Getty Images
hide caption
toggle caption
Maddie Meyer/Getty Images
